[HTML][HTML] Traditional Chinese medicine prolongs progression-free survival and enhances therapeutic effects in epidermal growth factor receptor tyrosine kinase …
M Tang, S Wang, B Zhao, W Wang, Y Zhu… - … medical journal of …, 2019 - ncbi.nlm.nih.gov
Traditional Chinese Medicine Prolongs Progression-Free Survival and Enhances
Therapeutic Effects in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)Treated …
Therapeutic Effects in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)Treated …
Chinese medicine combined with EGFR-TKIs prolongs progression-free survival and overall survival of non-small cell lung cancer (NSCLC) patients harboring EGFR …
Y Wang, G Wu, R Li, Y Luo, X Huang, L He… - Frontiers in Public …, 2021 - frontiersin.org
Objective: To explore the efficacy comparison between epidermal growth factor receptor–
tyrosine kinase inhibitors (EGFR-TKIs) combined with traditional Chinese medicine (TCM) …
tyrosine kinase inhibitors (EGFR-TKIs) combined with traditional Chinese medicine (TCM) …
[HTML][HTML] Combination of traditional Chinese medicine and epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of non-small cell lung cancer: A …
X Sui, M Zhang, X Han, R Zhang, L Chen, Y Liu… - Medicine, 2020 - journals.lww.com
Background: In China, traditional Chinese medicine (TCM) is an increasingly important part
of the treatment of non-small cell lung cancer (NSCLC), which usually includes a …
of the treatment of non-small cell lung cancer (NSCLC), which usually includes a …
Chinese herbal medicine combined with EGFR-TKI in EGFR mutation-positive advanced pulmonary adenocarcinoma (CATLA): a multicenter, randomized, double …
L Jiao, J Xu, J Sun, Z Chen, Y Gong, L Bi… - Frontiers in …, 2019 - frontiersin.org
Background: To determine the clinical activity and safety of Chinese herbal medicine (CHM)
combined with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) in …
combined with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) in …
Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol …
XB Yang, W Wu, S Long, H Deng, ZQ Pan, WF He… - Trials, 2015 - Springer
Background Patients with advanced non-small cell lung cancer (NSCLC) harboring
mutations of the epidermal growth factor receptor (EGFR) gene respond well to the EGFR …
mutations of the epidermal growth factor receptor (EGFR) gene respond well to the EGFR …
The Efficacy of Traditional Chinese Herbal Medicine in the Treatment of EGFR Mutated Stage IV Pulmonary Adenocarcinoma Patients Who Received First-Line EGFR …
HY Hung, YH Tseng, CM Liao… - Integrative cancer …, 2017 - journals.sagepub.com
Background. Chinese herbal medicine (CHM) has been used for thousands of year in
Eastern countries. First-line epidermal growth factor receptor (EGFR)-tyrosine kinase …
Eastern countries. First-line epidermal growth factor receptor (EGFR)-tyrosine kinase …
Chinese herbal medicine combined with first-generation EGFR-TKIs in treatment of advanced non-small cell lung cancer with EGFR sensitizing mutation: a systematic …
Y Lu, C Sun, L Jiao, Y Liu, Y Gong, L Xu - Frontiers in Pharmacology, 2021 - frontiersin.org
Background: Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related
deaths worldwide. First-generation epidermal growth factor receptor (EGFR) tyrosine kinase …
deaths worldwide. First-generation epidermal growth factor receptor (EGFR) tyrosine kinase …
Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic …
Z Liu, W Zhu, W Zhou, H Ying, L Zheng, Y Guo… - Journal of Integrative …, 2014 - Elsevier
Background Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) targeted
treatment has been a standard therapy for advanced non-small cell lung cancer (NSCLC) …
treatment has been a standard therapy for advanced non-small cell lung cancer (NSCLC) …
Qing‐Kai‐Ling Injection Acts Better Than Shen‐Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non‐Small Cell Lung Cancer Models
YY Yu, YJ Zhu, Y Zou, ZZ Xiao, S Shi… - Evidence‐Based …, 2021 - Wiley Online Library
Patients with EGFR gene mutation often obtain de novo resistance to epidermal growth
factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) or develop secondary resistance to …
factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) or develop secondary resistance to …
Adjunctive traditional Chinese medicine improves survival in patients with advanced lung adenocarcinoma treated with first-line epidermal growth factor receptor …
CL Li, TC Hsia, CH Li, KJ Chen… - Integrative cancer …, 2019 - journals.sagepub.com
Objectives: The clinical effect of traditional Chinese medicine (TCM) on survival in patients
with advanced lung adenocarcinoma treated with first-line epidermal growth factor receptor …
with advanced lung adenocarcinoma treated with first-line epidermal growth factor receptor …